Perforin Acts as an Immune Regulator to Prevent the Progression of NAFLD
Open Access
- 22 May 2020
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 11, 846
- https://doi.org/10.3389/fimmu.2020.00846
Abstract
Non-alcoholic fatty liver disease (NAFLD) is one of the main causes of cirrhosis and major risk factors for hepatocellular carcinoma and liver-related death. Despite substantial clinical and basic research, the pathogenesis of obesity-related NAFLD remains poorly understood. In this study, we show that perforin can act as an immune regulator to prevent the progression of NAFLD. Aged perforin-deficient (Prf−/−) mice have increased lipid accumulation in the liver compared to WT mice. With high-fat diet (HFD) challenge, Prf−/− mice have increased liver weight, more severe liver damage, and increased liver inflammation when compared with WT controls. Mechanistic studies revealed that perforin specifically regulates intrinsic IFN-γ production in CD4 T cells, not CD8 T cells. We found that CD4 T cell depletion reduces liver injury and ameliorates the inflammation and metabolic morbidities in Prf−/− mice. Furthermore, improved liver characteristics in HFD Prf−/− and IFN-γR−/− double knockout mice confirmed that IFN-γ is a key factor for mediating perforin regulation of NAFLD progression. Overall, our findings reveal the important regulatory role perforin plays in the progression of obesity-related NAFLD and highlight novel strategies for treating NAFLD.This publication has 50 references indexed in Scilit:
- Granule exocytosis mediates immune surveillance of senescent cellsOncogene, 2012
- Inflammation and Lipid Signaling in the Etiology of Insulin ResistanceCell Metabolism, 2012
- Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adultsAlimentary Pharmacology & Therapeutics, 2011
- Animal models of nonalcoholic fatty liver diseaseNature Reviews Gastroenterology & Hepatology, 2010
- Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connectionHepatology, 2010
- Apoptosis induced by the lymphocyte effector molecule perforinCurrent Opinion in Immunology, 2007
- Perforin enhances the granulysin-induced lysis of Listeria innocua in human dendritic cellsBMC Immunology, 2007
- Perforin-mediated target-cell death and immune homeostasisNature Reviews Immunology, 2006
- Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver diseaseJournal of Hepatology, 2004
- Development of insulitis without diabetes in transgenic mice lacking perforin-dependent cytotoxicity.The Journal of Experimental Medicine, 1996